Sofosbuvir, often marketed under various brand names, is an antiviral medication primarily used to treat hepatitis C infections. It belongs to a class of drugs known as nucleotide polymerase inhibitors and acts by inhibiting the replication of the hepatitis C virus (HCV) in the body. This groundbreaking medication has been a game-changer in the field of hepatology and has been instrumental in the quest to eliminate hepatitis C worldwide.
Sofosbuvir's mechanism of action is nothing short of revolutionary. It directly targets the hepatitis C virus, disrupting its ability to replicate and spread within the liver. The active ingredient, Sofosbuvir Tablets, acts as a chain terminator during viral RNA replication, effectively stopping the virus from multiplying. This active approach to combating the virus has proven to be highly effective, leading to improved cure rates and shorter treatment durations.